Extension Study to Evaluate the Safety and Immunogenicity of a Revaccination Dose of the RSVPreF3 OA Investigational Vaccine in Adults 60 Years and Older Who Participated in the RSV OA=ADJ-002 Study
Clinical trial NCT04657198 · COMPLETED
Trial details
- NCT number
- NCT04657198
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-09
- Primary completion
- 2021-06-03
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.